Oragenics Reports Positive Interim Safety Analysis Results from Its Phase 2 Clinical Trial of AG013 for Oral Mucositis Pharmaceutical Investing
Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression Biotech Investing
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018 Biotech Investing
Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts Cannabis Investing News
Clovis Oncology Announces European Commission Authorization of Rubraca (rucaparib) for Women with Recurrent Ovarian Cancer Pharmaceutical Investing
BioTime Announces $1.9 Million Grant for Continued Development of OpRegen® for Dry-AMD Biotech Investing
Phase III IMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone Pharmaceutical Investing
Novel First-In-Class Immunotherapeutic APVO210 Features Unique Mechanism of Action Delivering IL-10 Biotech Investing
